By using an inoculums-induced EAE female rat model of MS, we provide evidence that both IFN-β variants improve neurological status, reduce pro-inflammatory cytokines and astrocyte activation as well as enhance MOG and CNP-ase myelin protein levels in early stage of disease. Here, CNP is linked to myeloid sarcoma.